TMHC CEO Palmer Sheryl sold 13,513 shares at $72.06 (Sept 5); stock near 52-week high, 2 of 4 prior sales were well-timed at 90 days
Palmer Sheryl, Chairman, President and CEO, sold 13,513 shares of Taylor Morrison at $72.06 on 2025-09-05, reducing holdings from 384.0K to 370.5K shares. The sale occurred near the 52-week high of $74.80 and the stock has since climbed 10.7% in the past 30 days and 20.4% over 90 days. Historically, the CEO's prior sales at TMHC show mixed timing: 2 of 4 prior measurable sales were well-timed at the 90-day mark, though 1 of 5 was only recently executed on 2025-08-22 with no outcome yet determinable. The TMHC fundamentals remain solid with $2.0B in quarterly revenue and a relatively lean P/E of 7.89, suggesting the sale is not tied to broad operational deterioration.
CEO Palmer Sheryl sold 25,000 TMHC shares at $70.20 for $1.8M; stock now -9.9% from 52-week high.
Palmer Sheryl, Chairman, President and CEO, sold 25,000 shares at $70.20, reducing holdings by 6.1% to 384.0K shares. The sale occurred near the 52-week high (current price $67.38 is -9.9% from the $74.80 peak), though stock has appreciated 10.9% over the prior 30 days and 20.2% over 90 days. Examining his prior trades at TMHC specifically, 3 of 5 preceding sales showed negative 90-day returns (well-timed sells before declines), but this transaction's timing relative to future price action remains an open question. With the company showing strong fundamentals—$2.0B quarterly revenue, 10.1% annual growth, 7.40 P/E, and $193.6M net income—the sale by a senior executive merits monitoring to understand whether this reflects opportunistic liquidity or operational considerations.
